Periodontal inflammation is initiated by mucosal exposure to microbial organisms or their antigens. Mucosal epithelial cells, including those which line the oral cavity, have the capacity to modulate inflammatory responses to microbial infection, and do so with a high degree of fidelity. As part of the endogenous immune system, oral epithelia express of number of antimicrobial peptides, and recent studies indicate that endogenous lipid mediators generated during the resolution phase of inflammation promote epithelial protective responses to microbial products (e.g. endotoxin). At present, the mechanisms by which these resolution phase lipid mediators act are not known. Ongoing studies have revealed that oral epithelia express bactericidal permeability-increasing protein (BPI), a potent anti-infective molecule with microbial killing and endotoxin-neutralizing functions with previous expression attributed only to leukocytes. In preliminary data, we demonstrate that; a) oral epithelial BPI is functionally important in regulating epithelial responses to endotoxin and that resolution phase lipid mediators regulate epithelial expression of BPI. From these preliminary data, we hypothesize that epithelial antimicrobial peptides, including BPI, are central to mucosal resolution responses to microbial products during inflammation. Here, we will collaboratively pursue this hypothesis through three focused Specific Aims:
In Aim 1, we profile epithelial antimicrobial peptide regulation and function by resolution-phase lipid mediators.
In Specific Aim 2, we will define molecular details of resolution-phase lipid mediator regulation on oral epithelial antimicrobial expression.
In Aim 3, we will extend these findings to determine relevance of antimicrobial peptides to neutrophil-epithelial interactions. Each of these aims will incorporate a validation strategy in murine models and in human-derived materials. The long-term goals of this research are to elucidate the direct and indirect contribution of mucosal epithelia to inflammatory resolution Results from these experiments will reveal new insights into innate regulation of mucosal resolution and extensions of this work could lead to targets for experimental therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Specialized Center (P50)
Project #
5P50DE016191-05
Application #
7676063
Study Section
Special Emphasis Panel (ZDE1)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
5
Fiscal Year
2008
Total Cost
$266,839
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Van Dyke, T E; Hasturk, H; Kantarci, A et al. (2015) Proresolving nanomedicines activate bone regeneration in periodontitis. J Dent Res 94:148-56
Winkler, Jeremy W; Uddin, Jasim; Serhan, Charles N et al. (2013) Stereocontrolled total synthesis of the potent anti-inflammatory and pro-resolving lipid mediator resolvin D3 and its aspirin-triggered 17R-epimer. Org Lett 15:1424-7
Gao, Li; Faibish, Dan; Fredman, Gabrielle et al. (2013) Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J Immunol 190:689-94
Bartold, P Mark; Van Dyke, Thomas E (2013) Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 62:203-17
Hasturk, Hatice; Kantarci, Alpdogan; Van Dyke, Thomas E (2012) Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol 3:118
Petasis, Nicos A; Yang, Rong; Winkler, Jeremy W et al. (2012) Stereocontrolled total synthesis of neuroprotectin D1 / protectin D1 and its aspirin-triggered stereoisomer. Tetrahedron Lett 53:1695-1698
Hasturk, Hatice; Kantarci, Alpdogan; Van Dyke, Thomas E (2012) Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol 15:160-76
Schif-Zuck, Sagie; Gross, Nufar; Assi, Simaan et al. (2011) Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol 41:366-79
MacManus, Christopher F; Campbell, Eric L; Keely, Simon et al. (2011) Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization. FASEB J 25:1856-64
Serhan, Charles N; Petasis, Nicos A (2011) Resolvins and protectins in inflammation resolution. Chem Rev 111:5922-43

Showing the most recent 10 out of 139 publications